129 related articles for article (PubMed ID: 10708940)
1. Non-seminomatous ovarian germ cell tumours in children.
Baranzelli MC; Bouffet E; Quintana E; Portas M; Thyss A; Patte C
Eur J Cancer; 2000 Feb; 36(3):376-83. PubMed ID: 10708940
[TBL] [Abstract][Full Text] [Related]
2. An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique.
Baranzelli MC; Patte C; Bouffet E; Portas M; Mechinaud-Lacroix F; Sariban E; Roche H; Kalifa C
J Neurooncol; 1998 May; 37(3):229-39. PubMed ID: 9524081
[TBL] [Abstract][Full Text] [Related]
3. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
[TBL] [Abstract][Full Text] [Related]
4. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy.
Hollender A; Stenwig EA; Ous S; Fosså SD
Eur Urol; 1997; 31(2):141-7. PubMed ID: 9076455
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors.
Baranzelli MC; Kramar A; Bouffet E; Quintana E; Rubie H; Edan C; Patte C
J Clin Oncol; 1999 Apr; 17(4):1212. PubMed ID: 10561181
[TBL] [Abstract][Full Text] [Related]
7. [Ovarian malignant tumours. Efficacy of germ cell and sex cord tumour treatment protocol in Poland].
Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):803-10. PubMed ID: 17317911
[TBL] [Abstract][Full Text] [Related]
8. [Malignant non-seminomatous germinal tumors of the ovary. Experience of the French Society of Pediatric Oncology. 64 cases].
Baranzelli MC; Patte C; Bouffet E; Quintana E; Portas M; Vannier JP; Thyss A; Schmitt C; Flamant F
Contracept Fertil Sex; 1999 Feb; 27(2):133-9. PubMed ID: 10191568
[TBL] [Abstract][Full Text] [Related]
9. The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
Ledermann JA; Holden L; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD; Brampton M
Br J Urol; 1994 Aug; 74(2):225-30. PubMed ID: 7522874
[TBL] [Abstract][Full Text] [Related]
10. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
Culine S; Lhomme C; Kattan J; Duvillard P; Michel G; Droz JP
Eur J Cancer; 1994; 30A(9):1239-44. PubMed ID: 7528029
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique.
Bouffet E; Baranzelli MC; Patte C; Portas M; Edan C; Chastagner P; Mechinaud-Lacroix F; Kalifa C
Br J Cancer; 1999 Mar; 79(7-8):1199-204. PubMed ID: 10098759
[TBL] [Abstract][Full Text] [Related]
14. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical management.
De Corti F; Sarnacki S; Patte C; Mosseri V; Baranzelli MC; Martelli H; Conter C; Frappaz D; Orbach D
Surg Oncol; 2012 Jun; 21(2):e31-7. PubMed ID: 22459912
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for ovarian germ cell tumours.
Bower M; Fife K; Holden L; Paradinas FJ; Rustin GJ; Newlands ES
Eur J Cancer; 1996 Apr; 32A(4):593-7. PubMed ID: 8695258
[TBL] [Abstract][Full Text] [Related]
17. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477
[TBL] [Abstract][Full Text] [Related]
18. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.
Billmire D; Vinocur C; Rescorla F; Cushing B; London W; Schlatter M; Davis M; Giller R; Lauer S; Olson T;
J Pediatr Surg; 2004 Mar; 39(3):424-9; discussion 424-9. PubMed ID: 15017564
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Tscherry G; Jacky E; Jost LM; Stahel RA
Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
[TBL] [Abstract][Full Text] [Related]
20. Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study.
Duhil de Bénazé G; Pacquement H; Faure-Conter C; Patte C; Orbach D; Corradini N; Berger C; Sudour-Bonnange H; Vérité C; Martelli H; Fresneau B
Eur J Cancer; 2018 Mar; 91():30-37. PubMed ID: 29331749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
